543363

Prevest Denpro financials

Market cap
₹469 Cr
Sector
Healthcare
Calls analysed
3
Latest concall · Q4 FY26 · call held 29 Jun 2026

Prevest Denpro Q1 FY27

Revenue from Operations ₹71.81 cr +14%EBITDA ₹29.62 cr +13%EBITDA Margin 38.6% PAT ₹20.49 cr +13%

What went well

  • Revenue from operations for FY26 increased by 13.9% to INR 71.81 crores.
  • Export business recorded a growth of 17.58% during FY26.
  • EBITDA for FY26 increased by 13.3% to INR 29.62 crores.

What to watch

  • FY26 margin moderated marginally compared to the previous year.
  • Global business environment remained challenging throughout FY26 due to tariff-related developments, geopolitical tensions, and conflict.
Read the full call →

What Prevest Denpro does

Prevest DenPro makes dental materials and equipment covering restorative, endodontic, prosthodontic, preventive, aesthetic and orthodontic categories, manufactured at its Jammu facilities. It sells through a network of domestic dealers and overseas agents (B2B) as well as a direct-to-consumer online store, and runs an in-house R&D centre (Prevest Research Centre) for new-product development. It has recently added digital-dentistry offerings (3D-printed resins, printers, scanners) and a disinfectant-products line, and operates a US subsidiary, Axiodent Inc.

Segments

  • Dental materials
  • Dental equipment
  • Digital dentistry / 3D printing
  • Disinfectant products
Product portfolio
100+ dental materials/products
Manufacturing units
2 (Jammu, J&K)
Export reach
90+ countries
Dealer network (India)
60+
Overseas agents
90+
Total employees
250 (as of Mar-25)
Founded 1999Headquarters Jammu, IndiaEmployees 250 (FY25) Company website

Guidance record · Q4 FY26

what the last two calls moved 11 tracked 4 delivered 1 missed 6 open
  • New Product Launches delivered said Q4 FY25 Promised: Launch at least 4 to 5 new products in the 2025-2026 fiscal year Q4 FY26: Management confirmed commercialization of disinfectants and Rotoflex during the year, and R&D updates mentioned 2 new products hitting the market, meeting the lower end of the target range.
  • H2 Revenue Growth missed said Q2 FY26 Promised: Expect to cross 20% in the next half year Q4 FY26: Calculated H2 FY26 revenue growth was approximately 12% YoY, falling short of the >20% guidance, which management attributed to geopolitical tensions and supply chain disruptions in Q4.
  • Digital Dentistry Business Growth on track said Q4 FY25 Promised: Reach to a better level in 2026 Q4 FY26: Reported significant growth with 3D printer sales up 162% and 3D resins up 40.5% YoY. Capacity utilization for new products (including digital) is now at 18-20%. This demonstrates reaching a 'better level'.

All 11 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 20.9%, net profit up 27.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue16 15 18 16 19 +15%18 +23%19 +3%19 +21%
EBITDA6 5 7 5 7 +15%6 +11%7 +6%7 +27%
Net profit5 5 5 4 6 +15%5 +4%6 +13%6 +28%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −32.3% 1Y

₹400₹500₹600Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 20 Nov 2025Q4 FY26 — 29 Jun 2026

1Y: ₹602 on 10 Sept 2025 → ₹407.6. High ₹602 (10 Sept 2025), low ₹341.8 (30 Mar 2026).

How the price took the results

close before → close after

Q4 FY26
−2.1%
29 Jun
Q2 FY26
−1.0%
20 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 12.9% a year over 3 years, FY23 to FY26. Operating margin narrowed to 34.4%.

Year endingFY23FY24FY25FY26
Revenue₹50 Cr₹56 Cr₹63 Cr₹72 Cr
Operating profit₹20 Cr₹20 Cr₹22 Cr₹25 Cr
Operating margin39.3%35.2%35.0%34.4%
Interest₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Depreciation₹1 Cr₹1 Cr₹2 Cr₹2 Cr
Net profit₹16 Cr₹16 Cr₹18 Cr₹20 Cr
Net margin31.5%28.6%28.8%28.5%
Cash from operations₹10 Cr₹12 Cr₹15 Cr₹15 Cr
Free cash flow₹-3 Cr₹8 Cr₹13 Cr₹13 Cr
ROCE——25.0%24.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹0 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr
Reserves₹22 Cr₹45 Cr₹61 Cr₹77 Cr₹104 Cr₹113 Cr
Borrowings₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other liabilities₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹8 Cr₹8 Cr
Total liabilities₹31 Cr₹64 Cr₹79 Cr₹95 Cr₹123 Cr₹133 Cr
Fixed assets₹5 Cr₹7 Cr₹7 Cr₹27 Cr₹26 Cr₹27 Cr
Capital work in progress₹2 Cr₹5 Cr₹17 Cr₹0 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹7 Cr₹9 Cr
Other assets₹23 Cr₹52 Cr₹53 Cr₹66 Cr₹90 Cr₹98 Cr
Total assets₹31 Cr₹64 Cr₹79 Cr₹95 Cr₹123 Cr₹133 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, DIIs trimmed −0.43 pp while the public added +0.40 pp. The shareholder count grew 2% to 1,975.

Promoters
73.6%
FIIs
0.7%
DIIs
0.8%
Public
24.9%

Since Jun 2025

  • DIIs −0.43 pp
  • Public +0.40 pp
  • FIIs +0.02 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 73.6%, FIIs 0.3%, DIIs 0.7%, Public 25.4%.Dec '23: Promoters 73.6%, FIIs 0.3%, DIIs 0.7%, Public 25.4%.Mar '24: Promoters 73.6%, FIIs 0.5%, DIIs 0.7%, Public 25.2%.Jun '24: Promoters 73.6%, FIIs 1.1%, DIIs 0.7%, Public 24.6%.Sep '24: Promoters 73.6%, FIIs 0.6%, DIIs 0.7%, Public 25.1%.Dec '24: Promoters 73.6%, FIIs 0.6%, DIIs 0.7%, Public 25.1%.Mar '25: Promoters 73.6%, FIIs 0.6%, DIIs 1.3%, Public 24.5%.Jun '25: Promoters 73.6%, FIIs 0.6%, DIIs 1.2%, Public 24.5%.Sep '25: Promoters 73.6%, FIIs 0.6%, DIIs 0.8%, Public 25.0%.Dec '25: Promoters 73.6%, FIIs 0.7%, DIIs 0.8%, Public 25.0%.Mar '26: Promoters 73.6%, FIIs 0.7%, DIIs 0.8%, Public 25.0%.Jun '26: Promoters 73.6%, FIIs 0.7%, DIIs 0.8%, Public 24.9%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Prevest Denpro above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Atul Modi 37.52%unchanged
Namrata Modi 36.03%unchanged
Thermo Capital Private Limited 1.30%+0.16 pp
Pankaj Prasoon And (HUF) 1.20%unchanged
Ashika Global Finance Private Limited 1.13%newly disclosed
Sharad Kanayalal Shah 1.08%unchanged
Girish Paman Vanvari 1.02%unchanged
Pankaj Prasoon 1.00%−0.30 pp
Niharika Modi 0.03%unchanged
Alka Beotra 0.03%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Expensive

To justify its price of ₹408, this stock must grow earnings at 17% every year for 7 years. Our analysis caps realistic growth at ~9%. At that growth it is worth ₹276 — downside of 32%.

Growth the price implies
16.6% a year
for 7 years, fading to 4%
It has actually compounded at
9.3% a year
net profit, FY23–FY26 · EPS 9.3%
The gap
0.1 pp
-32% downside if it only repeats history
Price today ₹407.6 Value at the reference growth ₹276.12

Change the assumptions yourself →

All earnings calls (3)

Read the Q4 FY26 call →

Learn to analyse Prevest Denpro

Guides on how to read this kind of business and the numbers that matter.